PRA Health Sciences (PRAH) Tops Q2 EPS by 4c, Revenues Beat Offers FY18 Outlook

Go back to PRA Health Sciences (PRAH) Tops Q2 EPS by 4c, Revenues Beat Offers FY18 Outlook

PRA Health Sciences (PRAH) PT Raised to $115 at Barclays

August 2, 2018 5:08 AM EDT

Barclays raised its price target on PRA Health Sciences (NASDAQ: PRAH) to $115.00 (from $100.00) while maintaining a Overweight rating.

... More